Profil
Mr. Ralph was a Corporate Advisor principally in the biotechnology sector.
He holds a Degree in Pure and Applied Mathematics (University of Sydney), is Managing Director of The New Millennium Fund (Pooled Development Fund specialising in biotech).
He has 26 years of experience in the financial markets.
Mr Ralph has an established track record in taking scientific inventions from inception to the financial markets.
He has been a director (including roles as chairman and MD) of several public companies.
Ehemalige bekannte Positionen von Paul Ralph
| Unternehmen | Position | Ende |
|---|---|---|
| MEDIVAC LTD | Direktor/Vorstandsmitglied | 30.11.2007 |
| Colorado Investments Pty Ltd. | Präsident | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Growth Capital Group Ltd.
 Growth Capital Group Ltd. Electronic Equipment/InstrumentsElectronic Technology MediVac Ltd. engages in the developing and commercializing on-site, clinical waste conversion technology. It products include SunnyWipes, which consists of various antimicrobial hand hygiene and general cleaning products and Diakyne that identifies trace elements in body fluids using the Tracesmart technology. The company was founded on April 13, 1992 and is headquartered in Sydney, Australia. | Electronic Technology |
| Colorado Investments Pty Ltd. | Finance |
